3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Promyelocytic, Acute
20
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
9
Multiple Myeloma
9
Leukemia
8
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Uterine Cervical Neoplasms
3
Neuroblastoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Thrombocytopenia
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Blast Crisis
2
Interventions
Cisplatin
20
Surgical Procedures, Operative
9
Docetaxel
8
Cetuximab
8
Radiotherapy, Intensity-Modulated
7
Magnetic Resonance Spectroscopy
6
pembrolizumab
5
Specimen Handling
5
Radiotherapy
5
Fluorouracil
5
toripalimab
4
Surveys and Questionnaires
4
Radiation
4
Paclitaxel
4
Chemoradiotherapy
4
Celecoxib
4
X-Rays
3
Platinum
3
Counseling
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
camrelizumab
2
Taxes
2
Standard of Care
2
Psychiatric Rehabilitation
2
Practice Guidelines as Topic
2
Neoadjuvant Therapy
2
Narrow Band Imaging
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hypopharyngeal Neoplasms
×
Tretinoin
×
Clear all
NCT06706401
2026-04-24
LYSARI
Centre Leon Berard
Phase 3
Recruiting
460 enrolled